Pfizer (PFE) Begins Study on RSV Vaccine in Older Adults Posted byZacks Equity Research September 3, 2021 Leave a comment on Pfizer (PFE) Begins Study on RSV Vaccine in Older Adults Pfizer (PFE) starts a phase III study which will evaluate its respiratory syncytial virus vaccine candidate, RSVpreF in adults aged 60 years and above…